4.6 Article

Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells

Journal

PLOS ONE
Volume 10, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0134995

Keywords

-

Funding

  1. National Institutes of Health [U01-HG006398, U01-HL099776]
  2. Health Research Formula Fund HRFF - Pennsylvania Department of Health [554248]
  3. Institute for Regenerative Medicine of the University of Pennsylvania

Ask authors/readers for more resources

Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and therefore significantly hampers the feasibility of studies where a large number of iPSCs need to be derived. To develop higher throughput iPSC reprogramming methods, we generated iPSCs as a pooled culture using rigorous cell surface pluripotent marker selection with TRA-1-60 or SSEA4 antibodies followed by Magnetic Activated Cell Sorting (MACS). We observed that pool-selected cells are similar or identical to clonally derived iPSC lines from the same donor by all criteria examined, including stable expression of endogenous pluripotency genes, normal karyotype, loss of exogenous reprogramming factors, and in vitro spontaneous and lineage directed differentiation potential. This strategy can be generalized for iPSC generation using both integrating and non-integrating reprogramming methods. Our studies provide an attractive alternative to clonal derivation of iPSCs using rigorously selected cell pools and is amenable to automation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell & Tissue Engineering

Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants

Nerea Jimenez-Tellez, Carlos D. Vera, Zehra Yildirim, Julio Vicente Guevara, Tina Zhang, Joseph C. Wu

Summary: Long QT syndrome (LQTS) is a genetic cardiovascular disorder characterized by electrical conduction abnormalities, leading to arrhythmia, fainting, seizures, and an increased risk of sudden death. Researchers generated two human-induced pluripotent stem cell (iPSC) lines from LQT patients carrying a mutation in SNTA1 gene. These iPSC lines showed normal properties and pluripotency markers, making them valuable for studying the pathological mechanisms of LQTS related to the SNTA1 variant.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Exercise reprograms the inflammatory landscape of multiple stem cell compartments during mammalian aging

Ling Liu, Soochi Kim, Matthew T. Buckley, Jaime M. Reyes, Jengmin Kang, Lei Tian, Mingqiang Wang, Alexander Lieu, Michelle Mao, Cristina Rodriguez-Mateo, Heather D. Ishak, Mira Jeong, Joseph C. Wu, Margaret A. Goodell, Anne Brunet, Thomas A. Rando

Summary: Exercise can rejuvenate stem cells and improve tissue regeneration in aging animals. The cellular and molecular changes caused by exercise in various stem cell compartments have not been extensively studied. In this study, young and old mice were subjected to aerobic exercise and a comprehensive single-cell transcriptomic atlas of different stem cell types and their niche cells was generated. The study found that exercise ameliorated inflammatory pathways associated with old age and restored intercellular communication mediated by immune cells within these stem cell compartments. Exercise had a profound impact on the composition and transcriptomic landscape of circulating and tissue-resident immune cells.

CELL STEM CELL (2023)

Letter Cardiac & Cardiovascular Systems

Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction

Mengcheng Shen, Chun Liu, Shane Rui Zhao, Amit Manhas, Laksshman Sundaram, Mohamed Ameen, Joseph C. Wu

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option

Xuekun Wu, Francesca Vacante, Joseph C. Wu

EUROPEAN HEART JOURNAL (2023)

Review Physiology

Leveraging physiology and artificial intelligence to deliver advancements in health care

Angela Zhang, Zhenqin Wu, Eric Wu, Matthew Wu, Michael P. P. Snyder, James Zou, Joseph C. C. Wu

Summary: Artificial intelligence has greatly advanced in the field of health care over the past decade, especially in utilizing physiology data to transform and improve health care. This review explores the impact of past research on the field and identifies future challenges and directions. The focus is on artificial intelligence models, their application in automating health care tasks, increasing access to care, and enhancing capabilities. The review also addresses emerging concerns regarding individual physiology data and the challenges of deploying artificial intelligence models for meaningful clinical impact.

PHYSIOLOGICAL REVIEWS (2023)

Article Cell & Tissue Engineering

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations

Xiaohui Kong, Nadjet Belbachir, Wenshu Zeng, Christopher D. Yan, Sai Navada, Marco V. Perez, Joseph C. Wu

Summary: Catecholaminergic polymorphic ventricular tachycardia is a congenital arrhythmic syndrome caused by mutations on the RYR2 gene. Two patient-specific iPSC lines with RYR2 mutations were generated and evaluated for pluripotency, differentiation capability, and karyotype stability. These iPSC lines provide a valuable tool for studying the CPVT phenotype and underlying mechanisms.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients

Peter-James H. Zushin, Yang Zhou, Audrey Li, Euan A. Ashley, Matthew T. Wheeler, Joseph C. Wu

Summary: Dilated cardiomyopathies (DCM) are a leading cause of heart failure in aging populations. The chaperone protein BAG3 plays a significant role in the development of DCM and the rate at which it progresses to heart failure. In this study, two human induced pluripotent stem cell (iPSC) lines were generated from individuals with mutations in exon 3 of the BAG3 gene and their pluripotency and ability to differentiate into three primary germ layers were validated. These cell lines serve as a valuable model for studying BAG3 inactivation and insufficiency in relation to DCM.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Generation of two induced pluripotent stem cell lines from spinal muscular atrophy type 1 patients carrying no functional copies of SMN1 gene

Wenshu Zenga, Xiaohui Kong, Christina Alamanaa, Yu Liu, Jessica Guzman, Paul D. Pang, John W. Day, Joseph C. Wu

Summary: Spinal muscular atrophy (SMA) is a severe neurodegenerative muscular disease caused by the loss of survival of motor neuron 1 (SMN1) genes. Two iPSC lines were generated from SMA type I patients with SMN1 mutations, and their pluripotency and ability to differentiate into three germ layers were validated. These iPSC lines can be used to generate skeletal muscles to model the muscle atrophy of SMA, providing a complementary platform for in vitro drug screening.

STEM CELL RESEARCH (2023)

Article Cell Biology

CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth

Shasha Yin, Liu Liu, Lauren E. Ball, Yalong Wang, Mark T. Bedford, Stephen A. Duncan, Haizhen Wang, Wenjian Gan

Summary: This study identifies protein arginine methyltransferase 1 (PRMT1) as a critical regulator of the GATOR2 complex, which activates the mTORC1 pathway for tumor growth. Inhibition of the CDK5-PRMT1-WDR24 axis suppresses HCC cell proliferation and tumor growth. High PRMT1 protein expression is associated with elevated mTORC1 signaling in patients with HCC.

CELL REPORTS (2023)

Article Biology

A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B

Jui-Tung Liu, Caren Doueiry, Yu-lin Jiang, Josef Blaszkiewicz, Mary Paige Lamprecht, James A. A. Heslop, Yuri K. K. Peterson, Juliana Debrito Carten, Paula Traktman, Yang Yuan, Salman R. R. Khetani, Waleed O. O. Twal, Stephen A. A. Duncan

Summary: iPSC-derived hepatocytes were used to identify small molecule inhibitors of apoB secretion without causing steatosis. These inhibitors show effectiveness in reducing apoB secretion in cultured hepatocytes and humanized livers in mice. This research provides a potential solution for treating FH patients with hoFH mutations, with the identified small molecules having a distinct chemical structure from existing cholesterol lowering drugs.

COMMUNICATIONS BIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish

Syed Mukhtar Ahmed, Rabindra V. Shivnaraine, Joseph C. Wu

CIRCULATION (2023)

Article Cell & Tissue Engineering

Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients

Wenqiang Liu, Wenshu Zeng, Xiaohui Kong, Min Htet, Rebecca Yu, Matthew Wheeler, John W. Day, Joseph C. Wu

Summary: Researchers successfully generated two DMD induced pluripotent stem cell lines, which not only had pluripotency but also the capability to differentiate into cells of the three germ layers in the body. These cell lines can be used to model DMD in vitro and have the potential for therapeutic development.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Generation of two induced pluripotent stem cell lines from patients with Down syndrome

Wenjuan Zhu, Wenqiang Liu, Rebecca Yu, Melanie Manning, Anitra Waran Romfh, Joseph C. Wu

Summary: This study has successfully generated two induced pluripotent stem cell lines from two patients with Down syndrome, providing valuable resources for research and testing therapeutic strategies for this disorder.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations

Mao Zhang, Ravichandra Venkateshappa, Audrey Li, Michael B. Fowler, Melinda L. Telli, Joseph C. Wu

Summary: Researchers generated induced pluripotent stem cell (iPSC) lines from blood cells of breast cancer patients with germline ATM mutations. These patient-specific iPSC lines can differentiate into three germ layers and hold great potential for studying mechanisms and developing drug screening strategies for ATM-related cancer.

STEM CELL RESEARCH (2023)

Letter Cardiac & Cardiovascular Systems

Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells

Nadjet Belbachir, Yiyang Wu, Mengcheng Shen, Sophia L. Zhang, Joe Z. Zhang, Chun Liu, Bjorn C. Knollmann, Gholson J. Lyon, Ning Ma, Joseph C. Wu

CIRCULATION (2023)

No Data Available